M. Veslemes
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer-related Molecular Pathways
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 32
- Lung Cancer Research Studies 24
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 4
-
- Lung Cancer Treatments and Mutations 13
- Respiratory and Cough-Related Research 3
- Lung Cancer Diagnosis and Treatment 3
- Co-authors
- E. PapadakisXanthi TsiafakiVassilis GeorgouliasPh. PalamidasIoannis G. VlachonikolisA. RaptiA. AlexopoulosVassilis G. Gorgoulis
- Journals
- Lung Cancer (9 papers)Journal of Chemotherapy (4 papers)Annals of Oncology (2 papers)British Journal of Cancer (1 paper)Oncology Reports (1 paper)
- Partner nations
- GreeceUnited KingdomUnited States
In The Last Decade
M. Veslemes
38 papers receiving 978 citations
Peers
Comparison fields: 5 of 80
- Oncology 788
- Pulmonary and Respiratory Medicine 563
- Internal Medicine 25
- Cancer Research 92
- Epidemiology 197
Countries citing papers authored by M. Veslemes
This map shows the geographic impact of M. Veslemes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Veslemes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Veslemes more than expected).
Fields of papers citing papers by M. Veslemes
This network shows the impact of papers produced by M. Veslemes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Veslemes. The network helps show where M. Veslemes may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Veslemes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 61 | |
| 2 | 2006 | 7 | |
| 3 | 2004 | 50 | |
| 4 | 2004 | 51 | |
| 5 | 2003 | 24 | |
| 6 | 2002 | 14 | |
| 7 | 2002 | 11 | |
| 8 | 2001 | 29 | |
| 9 | 2001 | 108 | |
| 10 | 2001 | 276 | |
| 11 | 2000 | 28 | |
| 12 | 1999 | 7 | |
| 13 | 1999 | 2 | |
| 14 | 1998 | 17 | |
| 15 | 1998 | 90 | |
| 16 | 1997 | 4 | |
| 17 | C-erbB-2 oncoprotein expression in operable non-small cell lung cancer. | 1996 | 29 |
| 18 | 1995 | 6 | |
| 19 | 1993 | 17 | |
| 20 | 1993 | 5 |
About M. Veslemes
M. Veslemes is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Internal Medicine and Molecular Biology, having authored 39 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (24 papers), Cancer therapeutics and mechanisms (14 papers), Neuroendocrine Tumor Research Advances (13 papers), Lung Cancer Treatments and Mutations (13 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (4 papers), Respiratory and Cough-Related Research (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (788 citations), Pulmonary and Respiratory Medicine (563 citations), Internal Medicine (25 citations), Cancer Research (92 citations) and Epidemiology (197 citations). M. Veslemes has collaborated with scholars based in Greece, United Kingdom and United States. Frequent co-authors include E. Papadakis, Xanthi Tsiafaki, Vassilis Georgoulias, Ph. Palamidas, Ioannis G. Vlachonikolis, A. Rapti, A. Alexopoulos, Vassilis G. Gorgoulis, J. Jordanoglou and M. Agelidou. Their work appears in journals such as Lung Cancer, Journal of Chemotherapy, Annals of Oncology, British Journal of Cancer and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.